Posted in | Immuno-Oncology | Immunology

Developing miRNA Biomarker Technologies for Infection-Related Cancers Webinar

Review microRNA profiling and the use of multiplex technologies with Jordan Plieskatt of the Bethony Lab

Currently, more than half of the global cancer burden occurs in low-and middle-income countries, with 40% of those cancers related to infection.

Listen in as Jordan discusses his labs' use of multiplexing technologies for multiple miRNA detections from crude matrices in a large number of samples as required for cancer screening.

About the Presenter

Jordan Plieskatt leads the Biomarker Research group under Dr. Jeffrey Bethony at The George Washington University’s Department of Microbiology, Immunology & Tropical Medicine. He has more than eighteen years of experience in both protein chemistry and nucleic acid research.

In 2001, Jordan joined The George Washington University to lead the analytical and formulation unit as it advanced multiple vaccine development programs for neglected diseases of poverty, particularly Human Hookworm and Malaria. Today, he continues his work in vaccine development by consulting with organizations and program development partners to facilitate advancement of their efforts in neglected disease eradication.

In 2011, Jordan broadened his involvement in neglected disease research to include biomarker discovery and development of diagnostics. Focusing primarily on miRNAs and their utility in biomarker signatures for infection related cancers, he has integrated innovative technologies into laboratory workflows to minimize the time between bench discovery and field validation applications.

Jordan is the lead author in a number of recent publications related to miRNA biomarker development work currently focused on Opistorchis viverrini-induced cholangiocarcinoma and nasopharyngeal carcinoma.

Webinar Topics

  • Addressing the need for rapid and accurate identification of prognostic and diagnostic biomarkers for infection related cancers
  • Application of targeted and un-targeted technologies to miRNA biomarker discovery and their impact on downstream workflows integrating into a streamlined approach
  • From bench to field: Integrating field based approaches to miRNA development work early in your work for successful point of care

Other Webinars from Abcam

Life Science Webinars by Subject Matter